Search research articles
Contact Us
Filters
Showing results (1-10 of 383) with videos related to
Page
of 39
Sort By:
ESMO Open
|
November 15, 2018
Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?
Paolo Bossi
International Journal of Radiation Oncology, Biology, Physics
|
February 22, 2022
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
Lachlan McDowell, Paolo Bossi
Dermatology Practical & Conceptual
|
December 8, 2021
Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations
Paolo Bossi, Luigi Lorini
Current Treatment Options in Oncology
|
August 14, 2016
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer
Paolo Bossi, Salvatore Alfieri
Expert Opinion on Investigational Drugs
|
April 8, 2016
Investigational drugs for head and neck cancer
Paolo Bossi, Salvatore Alfieri
Critical Reviews in Oncology/Hematology
|
May 29, 2025
The loop between inflammation and late systemic toxicity in head and neck cancer survivors
Ilaria Mascagni, Paolo Bossi
Journal of Personalized Medicine
|
December 23, 2022
Personalized Medicine in Skull Base and Sinonasal Tumors
Davide Mattavelli, Paolo Bossi
Cancers of the Head & Neck
|
May 17, 2019
Radiotherapy plus EGFR inhibitors: synergistic modalities
Paolo Bossi, Francesca Platini
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2017
Toward Personalized Cancer Care for Elderly Head and Neck Cancer Patients
Ester Orlandi, Paolo Bossi
Expert Opinion on Emerging Drugs
|
September 26, 2023
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Andrea Esposito, Paolo Bossi
Page
of 39
Search research articles
Search
Showing results (1-10 of 383) with videos related to
Sort By:
Page
of 39
ESMO Open
|
November 15, 2018
Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?
Paolo Bossi
International Journal of Radiation Oncology, Biology, Physics
|
February 22, 2022
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
Lachlan McDowell, Paolo Bossi
Dermatology Practical & Conceptual
|
December 8, 2021
Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations
Paolo Bossi, Luigi Lorini
Current Treatment Options in Oncology
|
August 14, 2016
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer
Paolo Bossi, Salvatore Alfieri
Expert Opinion on Investigational Drugs
|
April 8, 2016
Investigational drugs for head and neck cancer
Paolo Bossi, Salvatore Alfieri
Critical Reviews in Oncology/Hematology
|
May 29, 2025
The loop between inflammation and late systemic toxicity in head and neck cancer survivors
Ilaria Mascagni, Paolo Bossi
Journal of Personalized Medicine
|
December 23, 2022
Personalized Medicine in Skull Base and Sinonasal Tumors
Davide Mattavelli, Paolo Bossi
Cancers of the Head & Neck
|
May 17, 2019
Radiotherapy plus EGFR inhibitors: synergistic modalities
Paolo Bossi, Francesca Platini
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2017
Toward Personalized Cancer Care for Elderly Head and Neck Cancer Patients
Ester Orlandi, Paolo Bossi
Expert Opinion on Emerging Drugs
|
September 26, 2023
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Andrea Esposito, Paolo Bossi
Page
of 39